Assembly Biosciences's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Assembly Biosciences is scheduled to report earnings on March 7, 2024, and the estimated EPS forecast is €-2.61. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	$ 153.00K	$ 0.00
Gross Profit	-	-	-	$ 153.00K	-
EBIT	$ -14.42M	$ -16.90M	$ -18.95M	$ -22.98M	$ -23.40M
EBITDA	$ -14.62M	$ -16.94M	$ -18.88M	$ -22.93M	$ -23.27M
Net Income Common Stockholders	$ -14.42M	$ -16.90M	$ -18.95M	$ -22.39M	$ -23.14M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 46.21M	$ 59.83M	$ 73.02M	$ 91.61M	$ 108.65M
Total Assets	$ 51.63M	$ 66.58M	$ 82.50M	$ 101.79M	$ 121.52M
Total Debt	$ 919.00K	$ 1.77M	$ 2.63M	$ 3.46M	$ 4.29M
Net Debt	$ -45.29M	$ -58.06M	$ -70.39M	$ -88.14M	$ -104.36M
Total Liabilities	$ 9.91M	$ 11.63M	$ 12.78M	$ 19.13M	$ 19.11M
Stockholders Equity	$ 41.71M	$ 54.95M	$ 70.33M	$ 82.66M	$ 102.40M
Cash Flow	-
Free Cash Flow	$ -13.98M	$ -13.68M	$ -23.43M	$ -19.25M	$ -19.92M
Operating Cash Flow	$ -13.85M	$ -13.63M	$ -23.43M	$ -19.25M	$ -19.82M
Investing Cash Flow	$ 18.88M	$ -8.37M	$ 10.00M	$ 16.56M	$ 31.43M
Financing Cash Flow	-	$ 134.00K	$ 4.49M	$ 437.00K	$ 0.00

Currency in USD

Assembly Biosciences Earnings and Revenue History

Income Statement >

Assembly Biosciences Debt to Assets

Balance Sheet >

Assembly Biosciences Cash Flow

Cash Flow >

Assembly Biosciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing